logo
Select company
Select metric
2.62Current Ratio
VS
Market
65
Sector
42
Industry
29
History
10
$ 3.99Close
$ 3.15 - $ 9.35 52-Week Range
Ticker Information

Ticker

FHTX

Company Name

FOGHORN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FOGHORN THERAPEUTICS INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FHTX - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 203.84M2.62$ 77.79M
3/31/2025$ 225.42M3.16$ 71.31M
12/31/2024$ 249.6M3.73$ 66.99M
9/30/2024$ 271.23M4.77$ 56.82M
6/30/2024$ 289.62M5.69$ 50.87M
3/31/2024$ 211.52M4.06$ 52.06M
12/31/2023$ 240.18M4.11$ 58.44M
9/30/2023$ 265.44M5.1$ 52.01M
6/30/2023$ 290.49M5.13$ 56.64M
3/31/2023$ 320.7M5.75$ 55.8M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FOGHORN THERAPEUTICS INC's latest trailing twelve months (TTM) Current Ratio stands at 1.33.
  • Over the past 5 years, FOGHORN THERAPEUTICS INC's average Current Ratio has been 5.77.
  • The median Current Ratio for FOGHORN THERAPEUTICS INC during this period was 5.41
  • FOGHORN THERAPEUTICS INC reached its highest Current Ratio over the past 5 years at 10.12.
  • The lowest Current Ratio recorded by FOGHORN THERAPEUTICS INC in the same timeframe 1.33

FOGHORN THERAPEUTICS INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
OABI : OMNIAB INC 3.77FENC : FENNEC PHARMACEUTICALS INC 4.85VYGR : VOYAGER THERAPEUTICS INC 5.43CAPR : CAPRICOR THERAPEUTICS INC 4.37LCTX : LINEAGE CELL THERAPEUTICS INC 4.08CCCC : C4 THERAPEUTICS INC 5.06ALMS : ALUMIS INC 6.05WHWK : WHITEHAWK THERAPEUTICS INC 20.41OCGN : OCUGEN INC 1.83EDIT : EDITAS MEDICINE INC 2.77

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for FOGHORN THERAPEUTICS INC is calculated as follows: AssetsC [ $ 16.89M ] / LiabilitesC [ $ 12.65M ]
(=) Current Ratio [ 1.33 ]

FHTX - Current Ratio, Last 5 years

1.33

Minimum

Dec 31, 2019

10.12

Maximum

Mar 31, 2021

5.77

Average

5.41

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44